Unraveling neuroHIV in the Presence of Substance Use Disorders.
J Neuroimmune Pharmacol. 2020 Nov 20;:
Authors: Lin Y, He JJ, Sorensen R, Chang L
This special issue contains 10 invited review papers that highlighted and extended the presentations at the NIDA-sponsored workshop « Unraveling NeuroAIDS in the Presence of Substance Use Disorders » at the 25th Society on NeuroImmune Pharmacology conference in 2019. The topics covered by these papers focused on the interactive, additive or synergistic effects of substance use disorders (SUD) with HIV infection on the immune system and on neuropathogenesis. These papers reviewed four categories of substances of abuse (opioids, tobacco, stimulants, and cannabis) and how comorbid HIV infection (including models with HIV proteins, HIV transgenic rodent models and SIV) might further impact the dysregulated dopaminergic and immune systems, and the subsequent neuropathogenesis and behavioral disorders known as HIV-associated neurological disorders (HAND). These reviews provided detailed background knowledge regarding how each of these addictive substances and HIV individually or collectively affected the immune system at the cellular, molecular and system levels, and the subsequent clinical and behavioral outcomes. The authors also identified gaps, confounds or constraints in the current disease models and approaches, and proposed future research directions.
PMID: 33215327 [PubMed – as supplied by publisher]
Source: ncbi 2